Felsher Lab In the Division of Oncology

The Felsher Lab current members

Lab Director

Dean Felsher, MD, PhD


Qiwei Yang Qiwei Yang
Transgenics manager
The most senior member of the Felsher lab, Qiwei Yang is responsible for maintaining the transgenic animals.
Mariola Liebersbach Mariola Liebersbach
Life Science Research Professional/Laboratory Manager
Working on translational projects and industry collaborations, in addition to laboratory management.
Ian Lai Ian Lai, PhD
Research Professional
Working on industry collaboration projects utilizing MRI and testing potential cancer therapeutics.
Hong Dai Hong Dai
Research Professional
Assisting in management of our transgenic colony.
  Leslie Quiroz
Administrative assistant

Instructors and Research Associates

Yulin Li Yulin Li, MD, PhD
Dr. Li has discovered the critical role of miR-17-92 in mediating MYC oncogene addiction. In collaboration with Dr. David Dill, he has also developed computational approaches to study the differentiation states of cancer cells. His research goal is to discover novel cancer therapeutics based on a mechanistic understanding of tumorigenesis. View more details.
Ling Tong, PhD
Utilizing intravital microscopy to interrogate the impact of MYC inhibition on tumor maintenance and regression.
Renu Dhanasekaran, MD Renu Dhanasekaran, MD
Pursuing basic and translational research in the field of hepatobiliary malignancies. The overall goal of my research is to identify biologically relevant prognostic biomarkers and molecular targets for drug therapy and consequently improve the clinical outcome of patients with hepatocellular carcinoma (HCC).

Post-Doctoral Fellows

Virginie Baylot

Virginie Baylot, PhD
Studying the role of the immune system in the mechanism by which the MYC/Twist induce metastasis in liver cancer.

Stephanie Casey, PhD
Investigating the role of the adaptive immune system in lymphoma regression upon oncogene inactivation.
Anja Deutzmann

Anja Deutzmann, PhD
Utilizing PET-imaging and intravital microscopy to interrogate the impact of MYC inhibition on tumor maintenance and regression.

Meital Gabay, PhD Meital (Gabay) Ryan, PhD
Dr. Gabay is a examining pathways that interact with MYC in the genesis and maintenance of liver cancer.
Arvin Gouw

Arvin Gouw, PhD
Investigating the metabolic mechanisms of oncogene addiction.

Daniel Koch, PhD Daniel Koch, PhD
Investigating biomarkers of oncogene-addicted cancer stem cells.
Srividya Swaminathan Srividya Swaminathan, PhD
Investigating the mechanisms of antigen-driven immune surveillance in oncogene-addicted lymphomas.

Medical Students

Nia Tope Adeniji Nia Tope Adeniji
Interested in using in vivo murine models to study the mechanisms of hepatocellular carcinoma (HCC) metastasis.
Michael Richardson Michael Richardson
Interests include clinical research in metastasis and oncogene-immune response relationships, particularly in melanoma.

Graduate Student

Delaney Sullivan

Delaney Sullivan
Characterizing potential drivers of MYC addicted lymphomas, with specific interest in proteins influencing chromatin architecture.

Undergraduate Student

Georgia Toal Theodore Hu
IInvestigating the role of the innate immune system in metastasized liver cancer.
Former Lab Members


Footer Links: